{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:48:01Z","timestamp":1788425281840,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13023-016-0394-2","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T01:37:07Z","timestamp":1454031427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?"],"prefix":"10.1186","volume":"11","author":[{"given":"Karen","family":"Anjema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris C.","family":"Hofstede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet M.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Estela","family":"Rubio\u2013Gozalbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike C.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien C.A.","family":"Boelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francjan J.","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"key":"394_CR1","first-page":"1667","volume-title":"The Metabolic and Molecular Bases of Inherited Disease. Volume II","author":"CR Scriver","year":"2001","unstructured":"Scriver CR, Kaufman S. Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. Volume II. 8th ed. New York: McGraw-Hill; 2001. p. 1667\u2013724.","edition":"8"},{"issue":"9750","key":"394_CR2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","volume":"376","author":"N Blau","year":"2010","unstructured":"Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet. 2010;376(9750):1417\u201327.","journal-title":"Lancet"},{"issue":"6","key":"394_CR3","doi-asserted-by":"crossref","first-page":"e1881","DOI":"10.1542\/peds.2012-3291","volume":"131","author":"S Keil","year":"2013","unstructured":"Keil S, Anjema K, van Spronsen FJ, Lambruschini N, Burlina A, Belanger-Quintana A, et al. Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study. Pediatrics. 2013;131(6):e1881\u20138.","journal-title":"Pediatrics"},{"issue":"3","key":"394_CR4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jpeds.2010.08.016","volume":"158","author":"BK Burton","year":"2011","unstructured":"Burton BK, Adams DJ, Grange DK, Malone JI, Jurecki E, Bausell H, et al. Tetrahydrobiopterin therapy for phenylketonuria in infants and young children. J Pediatr. 2011;158(3):410\u20135.","journal-title":"J Pediatr"},{"issue":"6","key":"394_CR5","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10545-012-9464-3","volume":"35","author":"O Leuret","year":"2012","unstructured":"Leuret O, Barth M, Kuster A, Eyer D, de Parscau L, Odent S, et al. Efficacy and safety of BH4 before the age of 4\u00a0years in patients with mild phenylketonuria. J Inherit Metab Dis. 2012;35(6):975\u201381.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"394_CR6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10545-010-9224-1","volume":"33","author":"RH Singh","year":"2010","unstructured":"Singh RH, Quirk ME, Douglas TD, Brauchla MC. BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up. J Inherit Metab Dis. 2010;33(6):689\u201395.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"394_CR7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S0007114511000298","volume":"106","author":"A MacDonald","year":"2011","unstructured":"MacDonald A, Ahring K, Dokoupil K, Gokmen-Ozel H, Lammardo AM, Motzfeldt K, et al. Adjusting diet with sapropterin in phenylketonuria: what factors should be considered? Br J Nutr. 2011;106(2):175\u201382.","journal-title":"Br J Nutr"},{"issue":"2","key":"394_CR8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","volume":"30","author":"D Modan-Moses","year":"2007","unstructured":"Modan-Moses D, Vered I, Schwartz G, Anikster Y, Abraham S, Segev R, et al. Peak bone mass in patients with phenylketonuria. J Inherit Metab Dis. 2007;30(2):202\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"9","key":"394_CR9","doi-asserted-by":"crossref","first-page":"e45165","DOI":"10.1371\/journal.pone.0045165","volume":"7","author":"P Solverson","year":"2012","unstructured":"Solverson P, Murali SG, Litscher SJ, Blank RD, Ney DM. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet. PLoS One. 2012;7(9):e45165.","journal-title":"PLoS One"},{"key":"394_CR10","first-page":"89","volume-title":"Physician\u2019s Guide to the Laboratory Diagnosis of Metabolic Disease","author":"N Blau","year":"2002","unstructured":"Blau N, Bonaf\u00e9 L, Blaskovics ME. Disorders of phenylalanine and tetrahydrobiopterin. In: Blau N, Duran M, Blaskovics M, Gibson KM, editors. Physician\u2019s Guide to the Laboratory Diagnosis of Metabolic Disease. 2nd ed. Heidelberg: Springer; 2002. p. 89\u2013106.","edition":"2"},{"issue":"4","key":"394_CR11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","volume":"77","author":"C Bernegger","year":"2002","unstructured":"Bernegger C, Blau N. High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002. Mol Genet Metab. 2002;77(4):304\u201313.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"394_CR12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1203\/00006450-199111000-00008","volume":"30","author":"A Ponzone","year":"1991","unstructured":"Ponzone A, Guardamagna O, Ferraris S, Ferrero GB, Dianzani I, Cotton RG. Tetrahydrobiopterin loading test in hyperphenylalaninemia. Pediatr Res. 1991;30(5):435\u20138.","journal-title":"Pediatr Res"},{"issue":"4","key":"394_CR13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ymgme.2009.01.002","volume":"96","author":"N Blau","year":"2009","unstructured":"Blau N, Belanger-Quintana A, Demirkol M, Feillet F, Giovannini M, MacDonald A, et al. Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria. Mol Genet Metab. 2009;96(4):158\u201363.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"394_CR14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1203\/01.PDR.0000111283.91564.7E","volume":"55","author":"H Shintaku","year":"2004","unstructured":"Shintaku H, Kure S, Ohura T, Okano Y, Ohwada M, Sugiyama N, et al. Long-term treatment and diagnosis of tetrahydrobiopterin-responsive hyperphenylalaninemia with a mutant phenylalanine hydroxylase gene. Pediatr Res. 2004;55(3):425\u201330.","journal-title":"Pediatr Res"},{"issue":"1","key":"394_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10545-009-9002-0","volume":"33","author":"JB Nielsen","year":"2010","unstructured":"Nielsen JB, Nielsen KE, Guttler F. Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation. J Inherit Metab Dis. 2010;33(1):9\u201316.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"394_CR16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10545-012-9458-1","volume":"35","author":"B Ziesch","year":"2012","unstructured":"Ziesch B, Weigel J, Thiele A, Mutze U, Rohde C, Ceglarek U, et al. Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life. J Inherit Metab Dis. 2012;35(6):983\u201392.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"394_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1750-1172-8-103","volume":"8","author":"K Anjema","year":"2013","unstructured":"Anjema K, van Rijn M, Hofstede FC, Bosch AM, Hollak CE, Rubio-Gozalbo E, et al. Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-h loading test and genotype. Orphanet J Rare Dis. 2013;8(1):103.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"394_CR18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","volume":"65","author":"I Smith","year":"1990","unstructured":"Smith I, Beasley MG, Ades AE. Intelligence and quality of dietary treatment in phenylketonuria. Arch Dis Child. 1990;65(5):472\u20138.","journal-title":"Arch Dis Child"},{"issue":"1\u20132","key":"394_CR19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","volume":"92","author":"SE Waisbren","year":"2007","unstructured":"Waisbren SE, Noel K, Fahrbach K, Cella C, Frame D, Dorenbaum A, et al. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. Mol Genet Metab. 2007;92(1\u20132):63\u201370.","journal-title":"Mol Genet Metab"},{"issue":"Suppl","key":"394_CR20","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.ymgme.2011.09.024","volume":"104","author":"K Anjema","year":"2011","unstructured":"Anjema K, Venema G, Hofstede FC, Carbasius Weber EC, Bosch AM, Ter Horst NM, et al. The 48-h tetrahydrobiopterin loading test in patients with phenylketonuria: evaluation of protocol and influence of baseline phenylalanine concentration. Mol Genet Metab. 2011;104(Suppl):S60\u20133.","journal-title":"Mol Genet Metab"},{"issue":"9","key":"394_CR21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.earlhumdev.2008.01.003","volume":"84","author":"F Feillet","year":"2008","unstructured":"Feillet F, Chery C, Namour F, Kimmoun A, Favre E, Lorentz E, et al. Evaluation of neonatal BH4 loading test in neonates screened for hyperphenylalaninemia. Early Hum Dev. 2008;84(9):561\u20137.","journal-title":"Early Hum Dev"},{"issue":"5","key":"394_CR22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","volume":"30","author":"BK Burton","year":"2007","unstructured":"Burton BK, Grange DK, Milanowski A, Vockley G, Feillet F, Crombez EA, et al. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. J Inherit Metab Dis. 2007;30(5):700\u20137.","journal-title":"J Inherit Metab Dis"},{"issue":"7","key":"394_CR23","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/humu.22320","volume":"34","author":"C Heintz","year":"2013","unstructured":"Heintz C, Cotton RG, Blau N. Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria. Hum Mutat. 2013;34(7):927\u201336.","journal-title":"Hum Mutat"},{"issue":"6 Pt 2","key":"394_CR24","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1542\/peds.112.S4.1566","volume":"112","author":"FK Trefz","year":"2003","unstructured":"Trefz FK, Blau N. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria. Pediatrics. 2003;112(6 Pt 2):1566\u20139.","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"394_CR25","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2005.05.013","volume":"86","author":"JB Hennermann","year":"2005","unstructured":"Hennermann JB, Buhrer C, Blau N, Vetter B, Monch E. Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria. Mol Genet Metab. 2005;86 Suppl 1:S86\u201390.","journal-title":"Mol Genet Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-016-0394-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T18:22:12Z","timestamp":1654194132000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ojrd.com\/content\/11\/1\/10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1186\/s13023-016-0394-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,29]]},"article-number":"10"}}